Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2694481055;81056;81057 chr2:178565302;178565301;178565300chr2:179430029;179430028;179430027
N2AB2530376132;76133;76134 chr2:178565302;178565301;178565300chr2:179430029;179430028;179430027
N2A2437673351;73352;73353 chr2:178565302;178565301;178565300chr2:179430029;179430028;179430027
N2B1787953860;53861;53862 chr2:178565302;178565301;178565300chr2:179430029;179430028;179430027
Novex-11800454235;54236;54237 chr2:178565302;178565301;178565300chr2:179430029;179430028;179430027
Novex-21807154436;54437;54438 chr2:178565302;178565301;178565300chr2:179430029;179430028;179430027
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Ig-139
  • Domain position: 65
  • Structural Position: 146
  • Q(SASA): 0.5025
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/E rs1199099522 0.414 0.892 N 0.428 0.252 0.301455362545 gnomAD-2.1.1 4.03E-06 None None None None N None 0 2.9E-05 None 0 0 None 0 None 0 0 0
K/E rs1199099522 0.414 0.892 N 0.428 0.252 0.301455362545 gnomAD-4.0.0 3.1831E-06 None None None None N None 0 4.5731E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.404 ambiguous 0.4158 ambiguous 0.071 Stabilizing 0.916 D 0.468 neutral None None None None N
K/C 0.7554 likely_pathogenic 0.7423 pathogenic -0.159 Destabilizing 0.999 D 0.672 neutral None None None None N
K/D 0.786 likely_pathogenic 0.7898 pathogenic -0.047 Destabilizing 0.987 D 0.588 neutral None None None None N
K/E 0.2789 likely_benign 0.3001 benign -0.045 Destabilizing 0.892 D 0.428 neutral N 0.485317873 None None N
K/F 0.8631 likely_pathogenic 0.8498 pathogenic -0.175 Destabilizing 0.999 D 0.665 neutral None None None None N
K/G 0.545 ambiguous 0.5392 ambiguous -0.11 Destabilizing 0.975 D 0.503 neutral None None None None N
K/H 0.428 ambiguous 0.4194 ambiguous -0.331 Destabilizing 0.997 D 0.589 neutral None None None None N
K/I 0.4096 ambiguous 0.4147 ambiguous 0.467 Stabilizing 0.983 D 0.683 prob.neutral N 0.506847938 None None N
K/L 0.4992 ambiguous 0.4977 ambiguous 0.467 Stabilizing 0.975 D 0.503 neutral None None None None N
K/M 0.3367 likely_benign 0.3456 ambiguous 0.188 Stabilizing 0.999 D 0.584 neutral None None None None N
K/N 0.6493 likely_pathogenic 0.6571 pathogenic 0.255 Stabilizing 0.967 D 0.515 neutral N 0.473315843 None None N
K/P 0.7016 likely_pathogenic 0.6907 pathogenic 0.362 Stabilizing 0.996 D 0.577 neutral None None None None N
K/Q 0.1856 likely_benign 0.1896 benign 0.1 Stabilizing 0.967 D 0.522 neutral N 0.500191324 None None N
K/R 0.0727 likely_benign 0.0746 benign 0.008 Stabilizing 0.025 N 0.243 neutral N 0.414148421 None None N
K/S 0.5579 ambiguous 0.5633 ambiguous -0.17 Destabilizing 0.916 D 0.455 neutral None None None None N
K/T 0.2682 likely_benign 0.2854 benign -0.03 Destabilizing 0.967 D 0.52 neutral N 0.455589982 None None N
K/V 0.4033 ambiguous 0.4051 ambiguous 0.362 Stabilizing 0.987 D 0.623 neutral None None None None N
K/W 0.8177 likely_pathogenic 0.7977 pathogenic -0.24 Destabilizing 0.999 D 0.681 prob.neutral None None None None N
K/Y 0.7545 likely_pathogenic 0.7405 pathogenic 0.12 Stabilizing 0.996 D 0.632 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.